Romania is one of the largest pharmaceutical markets in the Central and Eastern European region. However, its low per capita medicine expenditure reflects its relative lack of development compared to its more prominent Central European peers such as Poland, Czech Republic and Hungary. As such, growth opportunities are significant.

Eighth largest Central & Eastern European (CEE) market. Per capita spending is below the CEE average. The market will grow by a high US dollar CAGR. • Other medical devices and diagnostic imaging have the largest market shares. There is little local production, so much of the market is largely reliant on imports. The health sector is historically underdeveloped, poorly funded and poorly managed. Growing private healthcare sector. Continued World Bank support should maintain progress in developing the health sector. One of the CEE region's most populous countries.

Small but sophisticated medical device market. Imports supply most of the market. Other medical devices and diagnostic imaging have the largest market shares. High per capita spending in the Middle East Africa region. High single-digit market CAGR driven by the National Health Strategy.

The agricultural sector is responsible for one quarter of global greenhouse gas (GHG) emissions, and will play a central role as the world transitions to a low-carbon future. The livestock sector - and cattle ranching in particular - will be at the forefront of the policy debate, given its outsized contribution to emissions, but the transition will also impact the rest of the sector as governments move to regulate land and fertiliser use and incentivise the production of crop-based biofuels (see 'Environmental Regulation To Tackle Livestock & Fertilisers, Incentivise Biofuels', October 12 2017).

Second smallest market in the Asia Pacific (APAC) region. Per capita spending is one of the lowest in the world. Market growth will be below average for the region. Other medical devices and consumables have the largest market shares. The market is heavily reliant on imports. Domestic manufacturing is concentrated in Sialkot and centres mainly around steel surgical instruments and other hand held medical devices. Production is of a high quality but mostly destined for export.

Ambitious economic diversification plans coupled with a robust PPP framework will continue to attract foreign firms to the sultanate's infrastructure market. This will facilitate a sustained diversification of the competitive landscape. Our Key Projects Database indicates the dominance of domestic firms in Oman's construction sector has been eroded significantly since 2015 (when Omani firms accounted for 60% of the market). The market share of Omani firms has since fallen to 46%, a notable decline in such a short period (see 'Foreign Construction Players Increasing Market Share,' May 5 2015).

Fourth smallest market in the Middle East and Africa (MENA) region. Per capita spending of less than USD1 is the lowest in the MENA region. Moderate US dollar 2017-2022 CAGR, higher growth in local currency terms due to naira weakness Consumables is the largest product area. The orthopaedics & prosthetics market is particularly under-developed. Most requirements need to be imported as domestic production is negligible. Despite efforts to achieve universal health coverage and raise investment levels, the health sector is massively underfunded.

Small, underfunded market. Per capita medical device spending is below average for the MEA region. Market growth well above the global average forecast. Public hospital network is likely to be major purchaser due to out of date equipment. Universal health insurance system being implemented. Private sector set for a period of renewed growth as a result of moves to open up private clinics to commercial investors. Imports supply over 90% of the market. Capital investment projects rely on finance from sources outside Morocco. Training medical staff being prioritised.

The metallic stearates are defined as the metal salts of an 18-carbon chain fatty acid stearic acid. The global metallic stearates market has been segmented based on product, application, and region. In terms of product, the market has been categorized into five major segments, including zinc stearate, calcium stearate, aluminum stearate, magnesium stearate, and others. Zinc stearate is produced using Zn-salts such as ZnO, ZnCl2, and ZnSO4. Oxides, hydroxides, sulfate, and chloride salts of aluminum, magnesium, and calcium react with stearic acid to produce the respective salts. The others product scope includes nickel stearate, copper stearate, lithium stearate, and sodium stearate.